Mucosal immunity to severe acute respiratory syndrome coronavirus 2 infection-Reference-Cited by-同舟云学术

Mucosal immunity to severe acute respiratory syndrome coronavirus 2 infection

Published:2021-03-22 Issue:3 Volume:34 Page:181-186
ISSN:0951-7375
Container-title:Current Opinion in Infectious Diseases
language:en
Short-container-title:

Author:

Fröberg Janeri,Diavatopoulos Dimitri A.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Microbiology (medical)

Reference59 articles.

1. Virological assessment of hospitalized patients with COVID-2019;Wölfel;Nature,2020

2. Factors associated with disease severity and mortality among patients with COVID-19: a systematic review and meta-analysis;Chidambaram;PLoS One,2020

3. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China;Huang;Lancet,2020

4. Profiling Cases With Nonrespiratory Symptoms and Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infections in Mexico City;Bello-Chavolla;Clin Infect Dis,2020

5. Clinical characteristics of asymptomatic and symptomatic patients with mild COVID-19;Kim;Clin Microbiol Infect,2020

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mucosal immunity in COVID-19: a comprehensive review;Frontiers in Immunology;2024-08-14

2. Development of a colloidal gold-based immunochromatographic assay for rapid detection of nasal mucosal secretory IgA against SARS-CoV-2;Frontiers in Microbiology;2024-05-30

3. Subclinical SARS-CoV-2 Infections and Endemic Human Coronavirus Immunity Shape SARS-CoV-2 Saliva Antibody Responses;2024-05-22

4. Impaired Mucosal IgA Response in Patients with Severe COVID-19;2024

5. Clinical and laboratory considerations: determining an antibody-based composite correlate of risk for reinfection with SARS-CoV-2 or severe COVID-19;Frontiers in Public Health;2023-12-28